IntrinsicIntrinsic
← Scroll for more →

Bioventus Inc. (BVS)

Surgical & Medical Instruments & Apparatus

Latest Price
$13.63
TTM P/E
17.70
Normalized P/E
--
Div Yield
--
Book Value
3.38
P/B Ratio
4.04

Valuation metrics

adjust assumptions →
EPS: $0.33
Book value / share: $2.67
Formula: √(22.5 × EPS × BVPS)
Graham Number
$4.45
67% downside
Base FCF: $27M (median of recent 5yr)
Growth: 25%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$25.54
+87% upside
EPS: $0.33
Target P/E: 18×
Formula: EPS × P/E
P/E Fair Value
$5.94
56% downside

Institutional Ownership

78.7% held by institutions
InstitutionSharesValueOwnership %ChangeFiling Date
Essex Woodlands Management, Inc.13.02M$122.0M19.27%--2026-06-30
Juniper Investment Company, LLC6.94M$65.0M10.27%--2026-06-30
Nantahala Capital Management, LLC6.00M$56.0M8.88%-122.1K2026-06-30
BlackRock, Inc.3.44M$32.0M5.08%+302.4K2026-06-30
Royce & Associates LP1.83M$17.0M2.71%+291.9K2026-06-30
Vanguard Capital Management LLC1.75M$16.0M2.59%+37.0K2026-06-30
Geode Capital Management, LLC1.37M$12.0M2.02%+197.5K2026-06-30
American Century Companies Inc1.35M$12.0M2.00%+733.6K2026-06-30
Dimensional Fund Advisors LP1.13M$10.0M1.67%+255.3K2026-06-30
State Street Corp1.10M$10.0M1.63%+116.5K2026-06-30
View all institutional holders →